Metaphore Biotechnologies

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.metaphorebio.com/

Last Round

Early Funding

Apr 5, 2026

Total Funding Raised

$50M

Company Overview

Metaphore Biotechnologies is a biotechnology company that utilizes its proprietary MIMIC™ platform to design functional antibodies and therapeutic molecules based on biological dynamics and biomimicry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

computational drug discoveryAI drug discoverybiotech platformmolecular mimicryin silico drug designobesity therapeuticsmachine learning biologydrug discovery platformbiologicsmetabolic diseaseAI-native biotechcomputational biologytherapeutic designpharma partnershipprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metaphore Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

Metaphore Biotechnologies comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Metaphore Biotechnologies Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Apr 5, 2026
Series A	May 16, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Lovisa Afzelius

Co-founder Founding CEO

Founding Team

Metaphore Biotechnologies Investors

Notable investors and investment history

Metaphore Biotechnologies investors
Investor	Rounds
Global Brain Corporation	Early Funding
Flagship Pioneering	Early Funding, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 15, 2025
$600M collaboration to develop obesity therapeutics.
May 16, 2023
$50M raised in Seed round.

View all signals

Metaphore Biotechnologies Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Metaphore Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Metaphore Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range56

Year Founded2021

Last FundingApr 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.